Immunomodulation may influence cytokine release syndrome: In this context, an elevated serum concentration of interleukin-6 was observed and was associated with higher levels of SARS-CoV-2 viremia, progression to mechanical ventilation, and death [26,27,28,29]. This evidence concerns the gene IL6 and COVID-19.